CHRONIC HISTAMINE H-2-RECEPTOR BLOCKADE - EFFECTS ON CARDIAC ADRENERGIC RESPONSES

被引:0
|
作者
GROSS, SS [1 ]
LEVI, R [1 ]
机构
[1] CORNELL UNIV,MED CTR,COLL MED,NEW YORK,NY 10021
关键词
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:962 / 962
页数:1
相关论文
共 50 条
  • [41] CARDIAC PHARMACOLOGY OF ICI 125,211 - NEW HISTAMINE H-2-RECEPTOR ANTAGONIST
    TRZECIAKOWSKI, J
    LEVI, R
    FEDERATION PROCEEDINGS, 1980, 39 (03) : 389 - 389
  • [42] COMPARISON OF THE EFFECTS OF HISTAMINE H-1-RECEPTOR AND H-2-RECEPTOR ON LARGE AND SMALL AIRWAYS IN MAN
    WHITE, J
    EISER, NM
    THORAX, 1982, 37 (10) : 779 - 779
  • [43] EFFECTS IN MAN OF HISTAMINE H2-RECEPTOR BLOCKADE BY BURIMAMIDE
    WYLLIE, JH
    HESSELBO, T
    BLACK, JW
    LANCET, 1972, 2 (7787): : 1117 - &
  • [44] THE EFFECTS OF HISTAMINE H-2-RECEPTOR ANTAGONISTS ON PHA INDUCED LYMPHOCYTE-PROLIFERATION
    VICKERS, MR
    MILLINER, KJ
    FALLOWFIELD, C
    DRACOTT, BN
    AGENTS AND ACTIONS, 1984, 15 (3-4): : 242 - 248
  • [45] EFFECTS OF HOE-760 (HISTAMINE H-2-RECEPTOR ANTAGONIST) ON DIAZEPAM PHARMACOKINETICS
    MEYER, BH
    MULLER, FO
    BADIAN, M
    HUNDT, HKL
    JOUBERT, AL
    LUUS, HG
    SOUTH AFRICAN MEDICAL JOURNAL, 1988, 73 (07): : 421 - 423
  • [46] CHOLINERGIC-LIKE EFFECTS OF THE NEW HISTAMINE H-2-RECEPTOR ANTAGONIST RANITIDINE
    BERTACCINI, G
    CORUZZI, G
    AGENTS AND ACTIONS, 1982, 12 (1-2): : 168 - 171
  • [47] COMPARISON OF THE TUMOR-INHIBITING EFFECTS OF 3 HISTAMINE H-2-RECEPTOR ANTAGONISTS
    TUTTON, PJM
    BARKLA, DH
    ANTICANCER RESEARCH, 1983, 3 (01) : 7 - 10
  • [48] HISTAMINE INCREASES LUNG PERMEABILITY BY AN H-2-RECEPTOR MECHANISM
    BRAUDE, S
    COE, C
    ROYSTON, D
    BARNES, PJ
    LANCET, 1984, 2 (8399): : 372 - 374
  • [49] CARDIOVASCULAR EFFECTS IN MAN OF IMPROMIDINE, A NOVEL AND SPECIFIC HISTAMINE H-2-RECEPTOR AGONIST
    BOYCE, MJ
    BALASUBRAMANIAN, V
    WAREHAM, K
    BRITISH JOURNAL OF PHARMACOLOGY, 1980, 70 (01) : P157 - P158
  • [50] PHARMACOKINETICS OF RANITIDINE, A NEW HISTAMINE H-2-RECEPTOR BLOCKER
    GARG, DC
    WEIDLER, DJ
    BALTODANO, N
    ESHELMAN, FN
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (02) : 247 - 248